182 related articles for article (PubMed ID: 35671204)
1. Long-term follow-up of alkaptonuria patients: single center experience.
Bozaci AE; Yazici H; Canda E; Uçar SK; Guvenc MS; Berdeli A; Habif S; Coker M
J Pediatr Endocrinol Metab; 2022 Jul; 35(7):913-923. PubMed ID: 35671204
[TBL] [Abstract][Full Text] [Related]
2. Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria.
Hughes JH; Liu K; Plagge A; Wilson PJM; Sutherland H; Norman BP; Hughes AT; Keenan CM; Milan AM; Sakai T; Ranganath LR; Gallagher JA; Bou-Gharios G
Hum Mol Genet; 2019 Dec; 28(23):3928-3939. PubMed ID: 31600782
[TBL] [Abstract][Full Text] [Related]
3. Ashy ears.
Rallis E; Kintzoglou S
ScientificWorldJournal; 2010 Aug; 10():1530-1. PubMed ID: 20694448
[TBL] [Abstract][Full Text] [Related]
4. Structure-Function Relationship of Homogentisate 1,2-dioxygenase: Understanding the Genotype-Phenotype Correlations in the Rare Genetic Disease Alkaptonuria.
Bernini A; Spiga O; Santucci A
Curr Protein Pept Sci; 2023; 24(5):380-392. PubMed ID: 36880186
[TBL] [Abstract][Full Text] [Related]
5. Alkaptonuria in Turkey: Clinical and molecular characteristics of 66 patients.
Kisa PT; Gunduz M; Dorum S; Uzun OU; Cakar NE; Yildirim GK; Erdol S; Hismi BO; Tugsal HY; Ucar U; Gorukmez O; Gulten ZA; Kucukcongar A; Bulbul S; Sari I; Arslan N
Eur J Med Genet; 2021 May; 64(5):104197. PubMed ID: 33746036
[TBL] [Abstract][Full Text] [Related]
6. Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria.
Bernardini G; Laschi M; Geminiani M; Braconi D; Vannuccini E; Lupetti P; Manetti F; Millucci L; Santucci A
J Inherit Metab Dis; 2015 Sep; 38(5):807-14. PubMed ID: 25762405
[TBL] [Abstract][Full Text] [Related]
7. Alkaptonuria in Russia.
Soltysova A; Kuzin A; Samarkina E; Zatkova A
Eur J Hum Genet; 2022 Feb; 30(2):237-242. PubMed ID: 34504318
[TBL] [Abstract][Full Text] [Related]
8. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria.
Bernini A; Petricci E; Atrei A; Baratto MC; Manetti F; Santucci A
Sci Rep; 2021 Nov; 11(1):22562. PubMed ID: 34799606
[TBL] [Abstract][Full Text] [Related]
9. Homogentisate 1,2-dioxygenase (HGD) gene variants in young Egyptian patients with alkaptonuria.
Abdelkhalek ZS; Mahmoud IG; Omair H; Abdulhay M; Elmonem MA
Sci Rep; 2023 Sep; 13(1):14374. PubMed ID: 37658095
[TBL] [Abstract][Full Text] [Related]
10. The effect of nitisinone on homogentisic acid and tyrosine: a two-year survey of patients attending the National Alkaptonuria Centre, Liverpool.
Milan AM; Hughes AT; Davison AS; Devine J; Usher J; Curtis S; Khedr M; Gallagher JA; Ranganath LR
Ann Clin Biochem; 2017 May; 54(3):323-330. PubMed ID: 28081634
[TBL] [Abstract][Full Text] [Related]
11. Variant Analysis of Alkaptonuria Families with Significant Founder Effect in Jordan.
Khalil R; Ali D; Mwafi N; Alsaraireh A; Obeidat L; Albsoul E; Al Sbou' I
Biomed Res Int; 2021; 2021():1515641. PubMed ID: 34235214
[TBL] [Abstract][Full Text] [Related]
12. Use of nitisinone in patients with alkaptonuria.
Suwannarat P; O'Brien K; Perry MB; Sebring N; Bernardini I; Kaiser-Kupfer MI; Rubin BI; Tsilou E; Gerber LH; Gahl WA
Metabolism; 2005 Jun; 54(6):719-28. PubMed ID: 15931605
[TBL] [Abstract][Full Text] [Related]
13. Serum markers in alkaptonuria: simultaneous analysis of homogentisic acid, tyrosine and nitisinone by liquid chromatography tandem mass spectrometry.
Hughes AT; Milan AM; Davison AS; Christensen P; Ross G; Gallagher JA; Dutton JJ; Ranganath LR
Ann Clin Biochem; 2015 Sep; 52(Pt 5):597-605. PubMed ID: 25628464
[TBL] [Abstract][Full Text] [Related]
14. An update on molecular genetics of Alkaptonuria (AKU).
Zatkova A
J Inherit Metab Dis; 2011 Dec; 34(6):1127-36. PubMed ID: 21720873
[TBL] [Abstract][Full Text] [Related]
15. Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria.
Galderisi S; Milella MS; Rossi M; Cicaloni V; Rossi R; Giustarini D; Spiga O; Tinti L; Salvini L; Tinti C; Braconi D; Millucci L; Lupetti P; Prischi F; Bernardini G; Santucci A
Arch Biochem Biophys; 2022 Mar; 717():109137. PubMed ID: 35090868
[TBL] [Abstract][Full Text] [Related]
16. Alkaptonuria: a very rare metabolic disorder.
Aquaron R
Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955
[TBL] [Abstract][Full Text] [Related]
17. Urine homogentisic acid and tyrosine: simultaneous analysis by liquid chromatography tandem mass spectrometry.
Hughes AT; Milan AM; Christensen P; Ross G; Davison AS; Gallagher JA; Dutton JJ; Ranganath LR
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():106-12. PubMed ID: 24952314
[TBL] [Abstract][Full Text] [Related]
18. Alkaptonuria presenting with ochronotic spondyloarthropathy.
Al-Mahfoudh R; Clark S; Buxton N
Br J Neurosurg; 2008 Dec; 22(6):805-7. PubMed ID: 19085367
[TBL] [Abstract][Full Text] [Related]
19. Early-onset ocular ochronosis in a girl with alkaptonuria (AKU) and a novel mutation in homogentisate 1,2-dioxygenase (HGD).
Gucev ZS; Slaveska N; Laban N; Danilovski D; Tasic V; Pop-Jordanova N; Zatkova A
Prilozi; 2011; 32(1):305-11. PubMed ID: 21822197
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]